View drug registration information details.

Items	Registration information
ID	328
No	328
Brand Name	LIPIDUCE-20
Ingredients	ATORVASTATIN CALCIUM 21.70 MG EQ.TO ATORVASTATIN 20 MG
Dosage Form	TABLET
Primary Packaging	BLISTERPACK
Storage	STORE BELOW 30 C, PROTECT FROM LIGHT AND MOISTURE
Shelf Life	3 YEARS
Pack Size	BOX OF 3 X 10'S
Dispensing Category	Prescription only
ATC Classification	C10AA05
Pharmaceutical Class	ANTIHYPERLIDEMIA
Indications	AS AN ADJUNCT THERAPY TO DIET TO REDUCE ELEVATED TOTAL, LDL-CHOLESTEROL, APOLIPOPROTEINE B, TRIGLYCERIDES AND INCREASE HDL-CHOLESTEROL IN PATIENT WITH PRIMARY HYPERCHOLESTEROLEMIA ( HETEROZYGOUS FAMILIAL AND NONFAMILIAL), COMBINED HYPERLIPIDEMIA (FREDRICKSON TYPES IIA AND IIB), PRIMARY DYSETALIPOPROTEINEMIA
Contraindications	ACTIVE LIVER DISEASE OR UNEXPLAINED PERSISTENT ELEVATIONS OF SERUM TRANSAMINASE,. HYPERSENSITIVITY, PREGNANCY AND LACTATION
Side Effects	MYALGIA, MYOSITIS, RHABDOMYOLYSIS, CONSTIPATION, DIARRHEA, HEARTBURN, STOMACH PAIN, DIZZINESS, HEADACHE, NAUSEA, SKIN RASH, INSOMNIA
Unit Price	2.28
EDL	Yes
Description	WHITE COLOURED FILM COATED OVAL SHAPED TABLETS, SHALLOW CONVEX FACES, PLAIN ON BOTH SIDE.
Note
License Owner	BMS PHARMA SOLE CO.,LTD
Manufacturer	HOVID BHD
Country	MALAYSIA
Import Registration No	MAL12120002AZ
Import Registration Date	2017-12-28
Activity	CERTIFICATE RELEASED
Applied Date	2022-03-29
FDD Registration No	04 I 4689/19
FDD Registration Date	2022-09-08
Expiry Date	2025-09-07

Back to drug list